Clinical Trials Directory

Trials / Completed

CompletedNCT00232232

Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Melbourne Health · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate whether fish oils may be of benefit to patients with certain heart rhythm disturbances called atrial fibrillation and atrial flutter. Atrial fibrillation and atrial flutter are two heart conditions that can be successfully treated in the hospital by an ablation (in the case of atrial flutter) or a cardioversion (in the case of atrial fibrillation). Ablation involves the application of high frequency energy waves to a particular spot in the heart. Cardioversion involves resetting the heart back to a normal rhythm with the use of an electric current. Fish oil supplements may be of benefit to patients with heart problems. Recent evidence suggests that fish oils may benefit those with rhythm disturbances.

Conditions

Interventions

TypeNameDescription
DRUGFish oil

Timeline

Start date
2003-09-01
Primary completion
2013-07-01
Completion
2013-11-01
First posted
2005-10-04
Last updated
2015-05-12

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00232232. Inclusion in this directory is not an endorsement.

Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia (NCT00232232) · Clinical Trials Directory